Are changes in patient-reported outcomes prognostic for diffuse large B-Cell lymphoma survival? Results from the GOYA trial
Abstract In this hypothesis-generating analysis, we examined whether longitudinal changes in patient-reported outcomes (PROs), such as symptoms, over time would be prognostic for progression-free survival (PFS) and overall survival (OS) in patients with diffuse large B-cell lymphoma (DLBCL) who were...
Saved in:
Main Authors: | Jessie T. Yan (Author), Célia Bel (Author), Peter C. Trask (Author), Ernest Lo (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of prognostic factors in patients with diffuse large B-cell lymphoma
by: Fang Peng, et al.
Published: (2017) -
Survival in patients with oral and maxillofacial diffuse large B-cell lymphoma
by: Janet Ofelia Guevara-Canales, et al.
Published: (2013) -
Survival in patients with oral and maxillofacial diffuse large B-cell lymphoma
by: Janet Ofelia Guevara-Canales, et al.
Published: (2013) -
Goya
by: Crastre, François; Cooper, Frederic Taber, 1864-1937 [Translator] -
CHN1 is a Novel Prognostic Marker for Diffuse Large B-Cell Lymphoma
by: Sun J, et al.
Published: (2021)